Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis
EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]
Genprex CEO Commends FDA's Initiative to Accelerate Approval Process for Gene Therapies
Rodney Varner, CEO of Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies […]
OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia
OliX Pharmaceuticals, a leading developer of RNAi therapeutics, announced today that it has received approval […]
Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer
Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]
BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases
BIOTECanada welcomes the government’s dedicated investment of $1.5 B over 3 years to advance effective […]
Ionis Accounces FDA Advisory Committee Voted Unanimously for a Potential Accelerated Approval of Tofersen for SOD1-ALS
Ionis has announced the outcome of the United States Food and Drug Administration’s (FDA) Peripheral […]
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
Massive Bio, a private AI-enabled oncology startup that provides virtual and in-person concierge services for […]
Maze Therapeutics Announces New Clinical Data Supporting MZE001 as a Potential Treatment for Pompe Disease
Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced new data […]
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Needle-free Precision Delivery Systems
PharmaJet, a company engineering precision delivery systems that may overcome the challenges of nucleic acid […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more